Jordan Elm to Glyburide
This is a "connection" page, showing publications Jordan Elm has written about Glyburide.
Connection Strength
1.083
-
Effect of IV glyburide on adjudicated edema endpoints in the GAMES-RP Trial. Neurology. 2018 12 04; 91(23):e2163-e2169.
Score: 0.163
-
Long-Term Outcomes in Patients Aged =70 Years With Intravenous Glyburide From the Phase II GAMES-RP Study of Large Hemispheric Infarction: An Exploratory Analysis. Stroke. 2018 06; 49(6):1457-1463.
Score: 0.158
-
Safety and efficacy of intravenous glyburide on brain swelling after large hemispheric infarction (GAMES-RP): a randomised, double-blind, placebo-controlled phase 2 trial. Lancet Neurol. 2016 Oct; 15(11):1160-9.
Score: 0.140
-
Glyburide Advantage in Malignant Edema and Stroke (GAMES-RP) Trial: Rationale and Design. Neurocrit Care. 2016 Feb; 24(1):132-9.
Score: 0.134
-
Human Data Supporting Glyburide in Ischemic Stroke. Acta Neurochir Suppl. 2016; 121:13-8.
Score: 0.134
-
Exploratory analysis of glyburide as a novel therapy for preventing brain swelling. Neurocrit Care. 2014 Aug; 21(1):43-51.
Score: 0.121
-
Glyburide is associated with attenuated vasogenic edema in stroke patients. Neurocrit Care. 2014 Apr; 20(2):193-201.
Score: 0.118
-
Pilot study of intravenous glyburide in patients with a large ischemic stroke. Stroke. 2014 Jan; 45(1):281-3.
Score: 0.115